284 related articles for article (PubMed ID: 16424707)
21. Hemodynamic effects of inducible nitric oxide synthase and nitrotyrosine generation in heart failure.
Vanderheyden M; Bartunek J; Knaapen M; Kockx M; De Bruyne B; Goethals M
J Heart Lung Transplant; 2004 Jun; 23(6):723-8. PubMed ID: 15366433
[TBL] [Abstract][Full Text] [Related]
22. Mitochondrial nitric oxide synthase participates in septic shock myocardial depression by nitric oxide overproduction and mitochondrial permeability transition pore opening.
Xu C; Yi C; Wang H; Bruce IC; Xia Q
Shock; 2012 Jan; 37(1):110-5. PubMed ID: 21993446
[TBL] [Abstract][Full Text] [Related]
23. Effect of selective inhibition of renal inducible nitric oxide synthase on renal blood flow and function in experimental hyperdynamic sepsis.
Ishikawa K; Calzavacca P; Bellomo R; Bailey M; May CN
Crit Care Med; 2012 Aug; 40(8):2368-75. PubMed ID: 22622397
[TBL] [Abstract][Full Text] [Related]
24. A novel, potent and selective inhibitor of the activity of inducible nitric oxide synthase (GW274150) reduces the organ injury in hemorrhagic shock.
McDonald MC; Izumi M; Cuzzocrea S; Thiemermann C
J Physiol Pharmacol; 2002 Dec; 53(4 Pt 1):555-69. PubMed ID: 12512692
[TBL] [Abstract][Full Text] [Related]
25. Effects of norepinephrine plus dobutamine or norepinephrine alone on left ventricular performance of septic shock patients.
Martin C; Viviand X; Arnaud S; Vialet R; Rougnon T
Crit Care Med; 1999 Sep; 27(9):1708-13. PubMed ID: 10507587
[TBL] [Abstract][Full Text] [Related]
26. Comparison of equipressor doses of norepinephrine, epinephrine, and phenylephrine on septic myocardial dysfunction.
Ducrocq N; Kimmoun A; Furmaniuk A; Hekalo Z; Maskali F; Poussier S; Marie PY; Levy B
Anesthesiology; 2012 May; 116(5):1083-91. PubMed ID: 22407285
[TBL] [Abstract][Full Text] [Related]
27. Nitric oxide synthase inhibition versus norepinephrine for the treatment of hyperdynamic sepsis in sheep.
Booke M; Hinder F; McGuire R; Traber LD; Traber DL
Crit Care Med; 1996 May; 24(5):835-44. PubMed ID: 8706462
[TBL] [Abstract][Full Text] [Related]
28. Pulmonary oxidant stress in murine sepsis is due to inflammatory cell nitric oxide.
Razavi HM; Wang L; Weicker S; Quinlan GJ; Mumby S; McCormack DG; Mehta S
Crit Care Med; 2005 Jun; 33(6):1333-9. PubMed ID: 15942352
[TBL] [Abstract][Full Text] [Related]
29. Selective iNOS inhibition is superior to norepinephrine in the treatment of rat endotoxic shock.
Rosselet A; Feihl F; Markert M; Gnaegi A; Perret C; Liaudet L
Am J Respir Crit Care Med; 1998 Jan; 157(1):162-70. PubMed ID: 9445295
[TBL] [Abstract][Full Text] [Related]
30. [Effect of nitric oxide synthase inhibitors on the changes of hemodynamic parameters and aortic tension induced by septic shock in rats].
Xia ML; Zhou XM; Xu C; Qian LB; Xia Q
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2008 Aug; 24(3):279-84. PubMed ID: 21141582
[TBL] [Abstract][Full Text] [Related]
31. Effects of a selective iNOS inhibitor versus norepinephrine in the treatment of septic shock.
Su F; Huang H; Akieda K; Occhipinti G; Donadello K; Piagnerelli M; De Backer D; Vincent JL
Shock; 2010 Sep; 34(3):243-9. PubMed ID: 20160666
[TBL] [Abstract][Full Text] [Related]
32. [Effect of esmolol on fluid responsiveness and hemodynamic parameters in patients with septic shock].
Tao Y; Jingyi W; Xiaogan J; Weihua L; Xiaoju J
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2015 Nov; 27(11):885-9. PubMed ID: 27132454
[TBL] [Abstract][Full Text] [Related]
33. Effects of selective nitric oxide synthase inhibition in hyperdynamic endotoxemia in dogs.
Wolfárd A; Kaszaki J; Szabó C; Balogh Z; Nagy S; Boros M
Eur Surg Res; 1999; 31(4):314-23. PubMed ID: 10449990
[TBL] [Abstract][Full Text] [Related]
34. Inducible nitric oxide synthase (iNOS) gene deficiency increases the mortality of sepsis in mice.
Cobb JP; Hotchkiss RS; Swanson PE; Chang K; Qiu Y; Laubach VE; Karl IE; Buchman TG
Surgery; 1999 Aug; 126(2):438-42. PubMed ID: 10455918
[TBL] [Abstract][Full Text] [Related]
35. Echocardiographic and survival studies in mice undergoing endotoxic shock: effects of genetic ablation of inducible nitric oxide synthase and pharmacologic antagonism of platelet-activating factor.
Nicholson SC; Hahn RT; Grobmyer SR; Brause JE; Hafner A; Potter S; Devereux RB; Nathan CF
J Surg Res; 1999 Oct; 86(2):198-205. PubMed ID: 10534424
[TBL] [Abstract][Full Text] [Related]
36. Neuronal nitric oxide synthase and its interaction with soluble guanylate cyclase is a key factor for the vascular dysfunction of experimental sepsis.
Nardi GM; Scheschowitsch K; Ammar D; de Oliveira SK; Arruda TB; Assreuy J
Crit Care Med; 2014 Jun; 42(6):e391-400. PubMed ID: 24717470
[TBL] [Abstract][Full Text] [Related]
37. Disruption of inducible nitric oxide synthase improves beta-adrenergic inotropic responsiveness but not the survival of mice with cytokine-induced cardiomyopathy.
Funakoshi H; Kubota T; Kawamura N; Machida Y; Feldman AM; Tsutsui H; Shimokawa H; Takeshita A
Circ Res; 2002 May; 90(9):959-65. PubMed ID: 12016261
[TBL] [Abstract][Full Text] [Related]
38. MicroRNA-155 Amplifies Nitric Oxide/cGMP Signaling and Impairs Vascular Angiotensin II Reactivity in Septic Shock.
Vasques-Nóvoa F; Laundos TL; Cerqueira RJ; Quina-Rodrigues C; Soares-Dos-Reis R; Baganha F; Ribeiro S; Mendonça L; Gonçalves F; Reguenga C; Verhesen W; Carneiro F; Paiva JA; Schroen B; Castro-Chaves P; Pinto-do-Ó P; Nascimento DS; Heymans S; Leite-Moreira AF; Roncon-Albuquerque R
Crit Care Med; 2018 Sep; 46(9):e945-e954. PubMed ID: 29979224
[TBL] [Abstract][Full Text] [Related]
39. Sepsis-induced myocardial depression is associated with transcriptional changes in energy metabolism and contractile related genes: a physiological and gene expression-based approach.
dos Santos CC; Gattas DJ; Tsoporis JN; Smeding L; Kabir G; Masoom H; Akram A; Plotz F; Slutsky AS; Husain M; Sibbald WJ; Parker TG
Crit Care Med; 2010 Mar; 38(3):894-902. PubMed ID: 20101178
[TBL] [Abstract][Full Text] [Related]
40. HMG-CoA reductase inhibitor simvastatin profoundly improves survival in a murine model of sepsis.
Merx MW; Liehn EA; Janssens U; Lütticken R; Schrader J; Hanrath P; Weber C
Circulation; 2004 Jun; 109(21):2560-5. PubMed ID: 15123521
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
